Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1 b KEYNOTE-028 study.

被引：26
|
作者：
Mehnert, Janice M.
Varga, Andrea
Brose, Marcia
Aggarwal, Rahul Raj
Lin, Chia-Chi
Prawira, Amy
de Braud, Filippo
Tamura, Kenji
Doi, Toshihiko
Piha-Paul, Sarina Anne
Gilbert, Jill
Saraf, Sanatan
Thanigaimani, Pradeep
Cheng, Jonathan D.
Keam, Bhumsuk
机构：
[1] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[2] Gustave Roussy, Villejuif, France
[3] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Natl Taiwan Univ Hosp, Taipei, Taiwan
[6] Princess Margaret Canc Ctr, Toronto, ON, Canada
[7] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[8] Natl Canc Ctr Hosp Tokyo, Tokyo, Japan
[9] Natl Canc Ctr Hosp East, Chiba, Japan
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[12] Merck & Co Inc, Kenilworth, NJ USA
[13] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.6091
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6091
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Pembrolizumab in advanced endometrial cancer: Preliminary results from the phase Ib KEYNOTE-028 study.
    Ott, Patrick Alexander
    Bang, Yung-Jue
    Berton-Rigaud, Dominique
    Elez, Elena
    Pishvaian, Michael J.
    Rugo, Hope S.
    Puzanov, Igor
    Morgan, Mark Aloysuis
    Mehnert, Janice M.
    Aung, Kyaw Lwin
    Carrigan, Marion
    Saraf, Sanatan
    Chen, Mei
    Soria, Jean-Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [2] Pembrolizumab in patients with advanced cervical squamous cell cancer: Preliminary results from the phase Ib KEYNOTE-028 study.
    Frenel, Jean-Sebastien
    Le Tourneau, Christophe
    O'Neil, Bert H.
    Ott, Patrick Alexander
    Piha-Paul, Sarina Anne
    Gomez-Roca, Carlos Alberto
    Van Brummelen, Emilie
    Rugo, Hope S.
    Thomas, Shari
    Saraf, Sanatan
    Chen, Mei
    Varga, Andrea
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [3] Pembrolizumab for patients with advanced prostate adenocarcinoma: Preliminary results from the KEYNOTE-028 study
    Hansen, A.
    Massard, C.
    Ott, P. A.
    Haas, N.
    Lopez, J.
    Ejadi, S.
    Wallmark, J.
    Keam, B.
    Delord, J-P.
    Aggarwal, R.
    Gould, M.
    Qiu, P.
    Saraf, S.
    Keefe, S.
    Piha-Paul, S. A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] Preliminary results for the advanced salivary gland carcinoma cohort of the phase 1b KEYNOTE-028 study of pembrolizumab.
    Cohen, Roger B.
    Delord, Jean-Pierre
    Doi, Toshihiko
    Piha-Paul, Sarina Anne
    Liu, Stephen V.
    Gilbert, Jill
    Algazi, Alain Patrick
    Cresta, Sara
    Hong, Ruey-Long
    Le Tourneau, Christophe
    Day, Daphne
    Varga, Andrea
    Elez, Elena
    Wallmark, John M.
    Saraf, Sanatan
    Morosky, Anne
    Cheng, Jonathan D.
    Keam, Bhumsuk
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Updated results for the advanced esophageal carcinoma cohort of the phase 1b KEYNOTE-028 study of pembrolizumab
    Dol, Toshihiko
    Piha-Paul, Sarina Anne
    Jalal, Shadia Ibrahim
    Mai-Dang, Hieu
    Saraf, Sanatan
    Koshiji, Minori
    Csiki, Ildiko
    Bennouna, Jaafar
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study
    Hansen, A. R.
    Massard, C.
    Ott, P. A.
    Haas, N. B.
    Lopez, J. S.
    Ejadi, S.
    Wallmark, J. M.
    Keam, B.
    Delord, J. -P.
    Aggarwal, R.
    Gould, M.
    Yang, P.
    Keefe, S. M.
    Piha-Paul, S. A.
    ANNALS OF ONCOLOGY, 2018, 29 (08) : 1807 - 1813
  • [7] Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma Findings of the Phase 1b KEYNOTE-028 Study
    Cohen, Roger B.
    Delord, Jean-Pierre
    Doi, Toshihiko
    Piha-Paul, Sarina A.
    Liu, Stephen V.
    Gilbert, Jill
    Algazi, Alain P.
    Damian, Silvia
    Hong, Ruey-Long
    Le Tourneau, Christophe
    Day, Daphne
    Varga, Andrea
    Elez, Elena
    Wallmark, John
    Saraf, Sanatan
    Thanigaimani, Pradeep
    Cheng, Jonathan
    Keam, Bhumsuk
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (11): : 1083 - 1088
  • [8] Pembrolizumab (MK-3475) for patients (pts) with advanced esophageal carcinoma: Preliminary results from KEYNOTE-028
    Doi, Toshihiko
    Piha-Paul, Sarina Anne
    Jalal, Shadia Ibrahim
    Mai-Dang, Hieu
    Yuan, Sammy
    Koshiji, Minori
    Csiki, Ildiko
    Bennouna, Jaafar
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: Results from the KEYNOTE-158 and KEYNOTE-028 studies
    Piha-Paul, Sarina A.
    Oh, Do-Youn
    Ueno, Makoto
    Malka, David
    Chung, Hyun Cheol
    Nagrial, Adnan
    Kelley, Robin K.
    Ros, Willeke
    Italiano, Antoine
    Nakagawa, Kazuhiko
    Rugo, Hope S.
    de Braud, Filippo
    Varga, Andrea Iolanda
    Hansen, Aaron
    Wang, Hui
    Krishnan, Suba
    Norwood, Kevin G.
    Doi, Toshihiko
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (08) : 2190 - 2198
  • [10] Pembrolizumab (MK-3475) for patients (pts) with advanced colorectal carcinoma (CRC): Preliminary results from KEYNOTE-028
    O'Neil, B. H.
    Wallmark, J.
    Lorente, D.
    Elez, E.
    Raimbourg, J.
    Gomez-Roca, C.
    Ejadi, S.
    Piha-Paul, S. A.
    Moss, R. A.
    Siu, L. L.
    Dotti, K.
    Santoro, A.
    Gould, M.
    Yuan, S. S.
    Koshiji, M.
    Han, S. W.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S103 - S103
12345